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Abstract Decreased cell membrane integrity is a primary
pathological change observed in traumatic brain injury
(TBI) that activates a number of complex intercellular and
intracellular pathological events, leading to further neural
injury. In this paper, we assessed the effects of urinary
trypsin inhibitor (UTI) on astrocyte membrane integrity by
determining the percentage of lactate dehydrogenase
(LDH) released after sustained compression injury using a
hydrostatic pressure model of mechanical-like TBI.
Astrocytes isolated from SD rat pups were injured by
sustained compression. At a pressure of 0.3 MPa for 5 min,
a significant increase in LDH release was observed com-
pared with control samples. Astrocytes displayed extensive
structural disruption of mitochondrial cristae reflected in
their swelling. Based on our initial results, injured astro-
cytes were treated with UTI at a final concentration of 500,
1,000, 3,000 or 5,000 U/ml for 24 h. The percentage of
LDH released from injured astrocytes was significantly
decreased when 1,000 and 3,000 U/ml of UTI were used.
In a separate experiment, astrocytes were treated with UTI
at a final concentration of 1,000 U/ml immediately, or at
30 min, 2, 6, or 24 h after sustained compression. The
percentage of LDH release was significantly reduced
(P \ 0.05) when astrocytes were treated with UTI imme-
diately or 30 min later. Together, our results suggest that
UTI may have protective effects on astrocytes injured by
sustained compression injury. Furthermore, the early
administration (\2 h after injury) of UTI may result in a
better outcome compared with delayed administration.
Keywords Astrocytes  Compression injury 
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Introduction
Traumatic brain injury (TBI) is a significant cause of dis-
ability and death worldwide, and its incidence is rising
sharply. Current medical therapies exhibit limited efficacy
in reversing the initial damage and patients’ prognosis
remains poor [1], creating a significant burden for indi-
viduals, families and the society in general.
Early research on TBI focused almost exclusively on the
injury to neurons with little attention paid to astrocytes.
However, in the past decade, many new discoveries led to
the recognition of a critical role for astrocytes in the out-
come of TBI. Astrocytes, a sub-type of glial cells, are
ubiquitous throughout all regions of the central nervous
system (CNS). They outnumber neurons by more than
fivefold and contiguously tile the entire CNS [1]. Normal
astrocytes perform several functions, including: metabolic
support, regulation of blood flow, formation of the blood
brain barrier (BBB), transmitter uptake and release, mod-
ulation of synaptic transmission, and regulation of breath-
ing [2–8]. Astrocytes are vulnerable to CNS insults and are
severely damaged and die following TBI [9, 10]. Subse-
quently, reactive astrogliosis occurs in surviving astrocytes.
Reactive astrogliosis involves changes in gene expression,
morphology and proliferation in a gradated fashion in
relation to the severity of the injury [11–13]. Although the
exact details of the role of reactive astrocytes are not
completely understood, transgenic mice experiments
revealed that ablation of reactive astrocytes after CNS
injury causes substantial neuronal inflammation, degener-
ation, and death [14–16]. Therefore, astrocyte function is
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crucial for neurons, and affects outcomes following TBI,
making astrocytes an important therapeutic target for
neuronal protection following brain injury [17].
Damage to the integrity of cell membranes is the primary
pathological change observed in mechanically injured cells
[18]. It is a major contributor to the development of neu-
ronal damage because it results in the increased accumu-
lation of intracellular sodium, water and calcium ions, in
leakage of enzymes and cofactors, and in the activation of
cellular pathways [18]. Therefore we tested a therapeutic
strategy targeting the protection of damaged cell mem-
branes following TBI. Urinary trypsin inhibitor (UTI), one
of the serine-type protease inhibitors isolated from human
urine, inhibits not only a variety of proteases such as tryp-
sin, a-chymotrypsin, leukocyte elastases, and cathepsin G,
but also hyaluronidase [19]. Several studies demonstrated
that UTI may protect against systemic inflammation and
reduce the injury induced by pancreatitis, sepsis and
ischemia–reperfusion [20–22]. In CNS diseases, UTI may
have therapeutic effects in craniocerebral injuries, since it
decreases post-ischemic brain edema, oxidative stress, early
inflammation and ischemia-reperfusion injury [23, 24].
However, UTI’s protective effects against astrocyte mem-
brane damage after TBI have not been reported. Our study
demonstrates that UTI may have a cytoprotective effect on
astrocytes injured by sustained compression injury.
Materials and methods
Ethics statement
All procedures followed the National Guide for the Care
and Use of Laboratory Animals. All animal experiments
were approved by the Fujian Provincial Hospital Com-
mittee on Ethics in the Care and Use of Laboratory
Animals.
Cell culture
Astrocyte cultures were prepared using a previously
described method [25, 26]. Cortices were isolated from 1-
to 2-day-old rat pups, cleaned of white matter and
meninges, minced, and digested with 0.25 % trypsin–
EDTA (GIBCO, Invitrogen Inc., Carlsbad, CA, USA) for
20 min in a 37 C water bath. Cells were next diluted into
Dulbecco’s modified Eagle medium/nutrient mixture F-12
(DMEM/F12, Hyclone, Thermo Fisher Scientific Inc.,
Waltham, MA, USA) supplemented with 10 % fetal bovine
serum (FBS, Hyclone, Thermo Fisher Scientific Inc.,
Waltham, MA, USA), washed, triturated, counted and
seeded into 25-cm2 flasks (NUNC, Thermo Fisher Scien-
tific Inc., Waltham, MA, USA) at an initial density of
0.5–1 9 106 cells per flask. Flasks were cultured at 37 C
in 5 % CO2. The medium was changed every 2–3 days
until culture attained confluence. To remove neurons,
microglia and oligodendrocyte precursor cells, flasks were
shaken at 250 rpm for 18 h at 37 C in a temperature-
controlled orbital shaker (Shanghai Fuma Laboratory
Equipment Co., Ltd., Shanghai, China). After medium
removal, cells were trypsinized for 5-7 min. The trypsin
was diluted with DMEM/F12 supplemented with 10 %
FBS, thus allowing the cells to lift from the flask bottom.
The lifted cells were washed, centrifuged, counted, and
seeded into 25-cm2 flasks at a density of 0.5–1 9 106 cells
per flask. Astrocyte cultures were used in experiments for a
total of 4 weeks after removal from rats. Cultures consisted
of at least 95 % astrocytes as determined by glial fibrillary
acidic protein (GFAP) immunocytochemistry.
Cell injury
Astrocytes for injury experiments were placed in 48-well
(1.1 cm2 each) multidishes (NUNC, Thermo Fisher Sci-
entific Inc., Waltham, MA, USA). When the cells reached a
confluent monolayer, the DMEM/F12 was changed to
serum-free medium 1 day before the experiment. Astro-
cytes were injured using a pressure device developed by
Murphy and Horrocks [27]. Pressure was induced by
increasing atmospheric pressure within a stainless steel
chamber (19.5 cm in length, 19.5 cm in width, and 20 cm
in height). The chamber contained high-purity compressed
air (78 % nitrogen, 21 % oxygen, 0.93 % argon, 0.04 %
carbon dioxide). Pressure duration time was 1 or 5 min
with a pressure ranging from 0.1 to 0.3 MPa. The optimal
duration time and pressure were determined based on the
percentage of lactate dehydrogenase (LDH) released.
Control cultures were incubated at 37 C in 5 % CO2
during experimentation.
UTI administration
Astrocytes for experiments were placed in 48-well
(1.1 cm2 each) multidishes. When the cells reached a
confluent monolayer, the incubated medium for cells was
changed to serum-free medium 1 day before the experi-
ment. 0.3 MPa of pressure was administered to astrocytes
for 5 min. Subsequently, the injured cells were treated with
UTI (Techpool Bio-Pharma Co. Ltd., Guangzhou, China),
dissolved in serum-free culture medium at final concen-
trations of 100, 1,000, 3,000 and 5,000 U/ml, and main-
tained for 24 h.
Based on the results of the UTI intervention experiment,
astrocytes plated in 48-well multidishes were randomly
divided into 5 groups, according to the time of UTI
exposure; each group comprised 3 subgroups: control
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group, injury group, and UTI intervention group. Cells in
the UTI group were treated with UTI at a final concen-
tration of 1,000 U/ml immediately, or at 30 min, 2 h, 6 h,
and 24 h after sustained compression (0.3 MPa, 5 min).
LDH release
The degree of damage to cell membrane integrity has
previously been evaluated by measuring the percentage of
intracellular LDH released [18, 27–29]. LDH was mea-
sured using an in vitro toxicology assay kit (Sigma, St.
Louis, MO, USA). The assay is based on the reduction
reaction of nicotinamide adenine dinucleotide (NAD) by
LDH [30]. The extracellular medium was sampled after the
mechanical stimulus. The remaining intracellular LDH was
also measured after solubilizing the cells with 0.2 % Triton
X-100. The LDH release rate (%) was calculated using the
following equation:
LDH release ð%Þ ¼ Extracellurar LDH  100
Intracellular LDH þ Extracellular LDH
Transmission electron microscopic examination
Transmission electron microscope (TEM) was used to
examine the ultrastructural details of injured astrocytes.
Astrocytes were plated in 6-well (9.6 cm2 each well)
multidishes (NUNC, Thermo Fisher Scientific Inc., Wal-
tham, MA, USA). First, 0.3 MPa of pressure was admin-
istered to a monolayer of astrocytes for 5 min. Next, each
well was rinsed with phosphate-buffered saline (PBS, pH
7.4, GIBCO, Life Technologies Co., Waltham, MA, USA),
and trypsinized for 4–5 min. The trypsinized cells were
diluted with DMEM/F12 supplemented with 10 % FBS.
The lifted cells were centrifuged and fixed with 3 % glu-
taraldehyde and 1.5 % paraformaldehyde in PBS at room
temperature for 4 h. After being rinsed with PBS, samples
were fixed with 1 % osmic acid and 1.5 % potassium fer-
rocyanide at 4 C for 1.5 h. Samples were then dehydrated
with graded ethanol and acetone, embedded in epoxy resin,
and cut into ultra-thin slices of about 70–80 nm. Slices
were stained with uranyl acetate and lead citrate, and
observed under an EM208 TEM (Philips, Royal Dutch
Philips Electronics Ltd., Best, The Netherlands).
Statistical analysis
All data are presented as mean ± standard deviation (SD).
Statistical analyses were performed using the SPSS 13.0
software (SPSS Inc., Chicago, IL, USA). Statistical sig-
nificance was established by one-way analysis of variance
(ANOVA) followed by least significant difference (LSD)
t tests. P values \0.05 were considered to be significant.
Results
Pressure-induced cell LDH release and morphological
changes
No significant increase in the percentage of LDH release was
detected after exposure to increased pressure for a short
duration of time (1 min). When the duration of exposure was
increased to 5 min, a significant increase in LDH release from
astrocytes was observed at a pressure of 0.3 MPa (Fig. 1).
Astrocyte morphology was studied using TEM. Uninjured
astrocytes in the control group showed normal ultrastructural
features (Fig. 2a). On the other hand, injured astrocytes dis-
played structural abnormalities, including endoplasmic
reticulum swelling, mitochondrial cristae disruption and
Golgi apparatus vacuolization (Fig. 2b). Therefore, in the
following experiments, a pressure of 0.3 MPa for 5 min was
used to establish the sustained compression trauma model of
astrocytes.
Protective effect of UTI on injured astrocytes
The percentage of LDH release increased significantly in
injury samples (0.3 MPa, 5 min) compared with the control
samples. This result demonstrated that the astrocytes were
injured by sustained compression. After being treated with
UTI at concentrations of 1,000 and 3,000 U/ml for 24 h,
astrocytes released significantly less LDH compared with
injury samples. However, a higher UTI concentration
(5,000 U/ml) had no additional protective effect (Fig. 3).
In addition, the time-dependent effect of UTI adminis-
tration on LDH release after injury was also studied. After
being treated with 1,000 U/ml of UTI immediately, or
30 min post injury, astrocytes released significantly less
LDH compared with untreated injury samples. The
Fig. 1 Effects of sustained compression on LDH release from
astrocytes. Pressure duration of 1 or 5 min was used on astrocytes
over a pressure of 0.1, 0.2, or 0.3 MPa. LDH release was expressed as
a percent of the total releasable LDH (extracellular and intracellular
LDH). Values are presented as mean ± SD. *P \ 0.01 versus control
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protective effect was lost when astrocytes were treated with
UTI 2 h post-injury. At later time points, the percentage of
LDH released from injured astrocytes declined and no
statistically significant differences in LDH release were
detected among control, injury and UTI-treated group at 6
and 24 h post-injury (Fig. 4). This result demonstrated that
UTI may have protective effects on astrocytes at the early
stage of injury (\2 h after injury), and that membrane
damage may be irreversible following an early window of
recovery. Finally, our data also suggest that based on LDH
release, astrocytes eventually recovered from pressure-
induced injury in our model and that this recovery was
unaffected by UTI.
Discussion
Using a hydrostatic pressure model of mechanical-like TBI,
we studied the presumptive cytoprotective effects of UTI on
injured astrocytes in vitro. Although in vitro brain injury
models cannot surpass in vivo models, the former are able to
complement the latter, explore different aspects, provide
better control over experimental variables, and fulfill real
time and spatial measurement of biological and mechanical
parameters [31, 32]. The model employed in our research
was a nonelastic chamber where a constant hydrostatic
pressure was applied for a defined time, and compressed air
was used as the gas source in order to eliminate potentially
confounding factors such as ischemia and hypoxia. In cells
subjected to a high-pressure environment, once the lateral
compressions exceed the tolerance of cell membranes, cel-
lular membrane integrity is compromised. According to the
studies of Murphy and Horrocks [27], the effect of sustained
hydrostatic pressure-induced injury depended on pressure
and pressure duration, and these two parameters varied for
different types of cells. Based on these results, we tested
pressure durations of 1 and 5 min over a pressure range of
0.1, 0.2, and 0.3 MPa on astrocytes. At a pressure of 0.3 MPa
during 5 min, a significant increase in LDH released from
astrocytes was observed. The increase in cytoplasmic
enzyme efflux is an indicator of compromised cell membrane
integrity. In addition, injured astrocytes displayed ultra-
structural abnormalities, including endoplasmic reticulum
swelling, mitochondrial cristae disruption and Golgi appa-
ratus vacuolization, and these abnormalities were in accor-
dance with an increased LDH release. These morphological
abnormalities implied that certain cell functions may be
impaired, such as the production and transport of proteins,
energy conversion, and oxidative phosphorylation. These
Fig. 2 Astrocyte morphology before and after sustained compression injury. a Normal ultrastructural features of uninjured astrocytes.
b Ultrastructural abnormalities in astrocytes injured by sustained compression injury (0.3 MPa for 5 min)
Fig. 3 Effects of different concentrations of UTI on LDH release
from injured astrocytes. *P \ 0.05 versus control; **P \ 0.01 versus
injury. The amount and duration of pressure for the injury and UTI
group were 0.3 MPa and 5 min. LDH release was expressed as a
percent of the total releasable LDH (extracellular and intracellular
LDH). Values are presented as mean ± SD
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results show that a hydrostatic pressure model of mechani-
cal-like TBI on astrocytes was successfully established, and
that the injured cells were characterized by decreased cell
membrane integrity and ultrastructural abnormalities. Thus,
LDH assay alone was used in our experiments.
Cell membrane integrity damage is a primary patho-
logical change after mechanical neuronal injury. It is also
the major contributor to the development of neuronal
damage resulting in ionic imbalances and activation of
several cellular pathways [18]. There are several ways to
assess cell membrane integrity, including vital dye staining
and measurement of cytoplasmic enzyme release. Vital
dyes, such as trypan blue and propidium iodide (PI), are
easily used and cheap, but they are usually time-consuming
and do not allow the processing of a large number of
samples. Furthermore, they do not account for the pro-
portion of dead cells, and the actual rate of cell death may
thus be underestimated [33]. In contrast, measurement of
cytoplasm enzymes release is more accurate, easily auto-
mated, and reliably quantifies neuroprotective effects [34],
and LDH is the most commonly assessed among these
enzymes. Compared with other released enzymes (such as
glucose-6-phosphate dehydrogenase, which has a half-life
of *2 h in culture medium), LDH is more stable [35].
Moreover, the percentage of LDH released was used to
characterize membrane damage instead of the amount of
LDH released. Apart from cell membrane integrity, the
amount of LDH efflux is also associated with the number
of cells present. Therefore, the percentage of LDH release,
a ratio of the amount of LDH efflux to the total LDH, was
used to eliminate the influence of the number of cells on
our quantification of LDH release.
Our studies demonstrated that the treatment of injured
astrocytes with UTI at a concentration of 1,000 or 3,000 U/
ml significantly improved cell membrane integrity. In
addition, the timing of UTI administration was also critical.
The mechanism underlying the cytoprotective effects of
UTI on injured astrocytes may involve the inhibition of
hydrolytic enzymes released from lysosomes. Lysosomes
are membrane-bound vesicles serving as the cell’s main
digestive compartment. Lysosomes contain numerous
hydrolytic enzymes, including proteases, peptidases,
phosphatases, nucleases, sulphatases and lipases. Together,
these hydrolytic enzymes are capable of digesting all cel-
lular components. In healthy cells, the lysosomal mem-
brane protects cellular components from these degradative
enzymes [36]. However, acute brain injury such as trauma,
seizures and ischemia can result in the increase of free
intracellular calcium and zinc. Calcium and zinc toxicity
may contribute to lysosomal membrane permeabilization,
disintegration and leakage of hydrolytic enzymes leading
to the digestion of cellular components. This process is one
of the major cascades involved in astrocyte necrosis [37–
41]. Lysosomal enzyme inhibitors may therefore be neu-
roprotective in brain injury. Being a serine-type protease
inhibitor, UTI may protect cell proteins from digestion by
inhibiting lysosomal proteases. In this way, UTI may sta-
bilize the membrane of lysosomes and promote the re-
sealing of disrupted cell membranes. However, increasing
UTI dose to 5,000 U/ml had no further effect compared
with the 3,000 U/ml dose. This may be due to the fact that
UTI is an inhibitor of a variety of proteases and that high
UTI doses may interfere with normal cellular proteolytic
processes, thus counter-balancing its beneficial effects.
In conclusion, UTI may have cytoprotective effects on
astrocytes injured by sustained compression trauma due to
the improvement of cell membrane integrity. Time-
dependent treatment is essential as the early administration
(\2 h after injury) of UTI resulted in better protection
compared with the delayed administration.
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Fig. 4 Time-dependent effects of UTI on LDH release from injured
astrocytes. *P \ 0.01 versus control; *aP \ 0.05 versus control;
**P \ 0.01 versus injury. The amount and duration of pressure for
the injury and UTI groups were 0.3 MPa and 5 min. LDH release was
expressed as a percent of the total releasable LDH (extracellular and
intracellular LDH). Values are presented as mean ± SD
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